﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/moderna-announces-positive-phase-3-efficacy-data-for-next-generation-covid-19-vaccine-15761</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/usfda-approves-expanded-age-indication-for-gsks-rsv-vaccine-arexvy-15762</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/farxiga-approved-in-the-us-for-the-treatment-of-paediatric-type-2-diabetes-15763</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/axosim-appoints-alif-saleh-as-ceo-15764</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/suven-to-acquire-a-majority-stake-in-cdmo-player-sapala-organics-15765</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/usfda-inspection-of-lupins-nagpur-injectable-facility-with-zero-483-observations-15766</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-receives-usfdas-tentative-approval-for-azilsartan-medoxomil-and-chlorthalidone-tablets-15767</loc><lastmod>2024-06-14T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>